glp-1 and dual glp-1/gip receptor agonists The Sustained Effects of a GIP/GLP-1 Agonist, NNC0090-2746, in Patients with Type 2 Diabetes Demonstrated metabolic effects of GIP,

More research is needed in humans, however, before this claim can be fully supported

Glutamate is released at synapses throughout the brain, and exerts changes in postsynaptic excitability and neuroplasticity (68)

Current treatment options for PACS still primarily emphasize managing the symptoms but neglect the underlying cause, such as persistent inflammation, immune dysfunction, and tissue damage

L-carnitine, which is often available over-the-counter, is known for its potential anti-obesity, anti-diabetic and lipid-improving effects

This podcast is full of outstanding practical tips and should be reviewed over and over

Abstract Acute renal failure (ARF) is a sudden, significant, and often reversible decline in kidney function, with 25% of all hospital-administered pharmaceuticals potentially causing nephrotoxicity